Open Access

Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)

  • Authors:
    • Caifeng Wan
    • Fenghua Li
    • Hongli Li
  • View Affiliations

  • Published online on: July 7, 2015     https://doi.org/10.3892/mmr.2015.4054
  • Pages: 4803-4814
  • Copyright: © Wan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The eye is an ideal target organ for gene therapy as it is easily accessible and immune‑privileged. With the increasing insight into the underlying molecular mechanisms of ocular diseases, gene therapy has been proposed as an effective approach. Successful gene therapy depends on efficient gene transfer to targeted cells to prove stable and prolonged gene expression with minimal toxicity. At present, the main hindrance regarding the clinical application of gene therapy is not the lack of an ideal gene, but rather the lack of a safe and efficient method to selectively deliver genes to target cells and tissues. Ultrasound‑targeted microbubble destruction (UTMD), with the advantages of high safety, repetitive applicability and tissue targeting, has become a potential strategy for gene‑ and drug delivery. When gene‑loaded microbubbles are injected, UTMD is able to enhance the transport of the gene to the targeted cells. High‑amplitude oscillations of microbubbles act as cavitation nuclei which can effectively focus ultrasound energy, produce oscillations and disruptions that increase the permeability of the cell membrane and create transient pores in the cell membrane. Thereby, the efficiency of gene therapy can be significantly improved. The UTMD‑mediated gene delivery system has been widely used in pre‑clinical studies to enhance gene expression in a site‑specific manner in a variety of organs. With reasonable application, the effects of sonoporation can be spatially and temporally controlled to improve localized tissue deposition of gene complexes for ocular gene therapy applications. In addition, appropriately powered, focused ultrasound combined with microbubbles can induce a reversible disruption of the blood‑retinal barrier with no significant side effects. The present review discusses the current status of gene therapy of ocular diseases as well as studies on gene therapy of ocular diseases meditated by UTMD.
View Figures
View References

Related Articles

Journal Cover

October-2015
Volume 12 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wan C, Li F and Li H: Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review). Mol Med Rep 12: 4803-4814, 2015
APA
Wan, C., Li, F., & Li, H. (2015). Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review). Molecular Medicine Reports, 12, 4803-4814. https://doi.org/10.3892/mmr.2015.4054
MLA
Wan, C., Li, F., Li, H."Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)". Molecular Medicine Reports 12.4 (2015): 4803-4814.
Chicago
Wan, C., Li, F., Li, H."Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)". Molecular Medicine Reports 12, no. 4 (2015): 4803-4814. https://doi.org/10.3892/mmr.2015.4054